Evaluation of blood rheology in patients with cyanotic congenital heart disease using a microchannel array flow analyzer

Clinical Hemorheology and Microcirculation

Volumn 35, Issue 4, 2006, Pages 499-508

  Katayama, Yasutomi ^a   Horigome, Hitoshi ^a   Murakami, Takashi ^a   Takahashi Igari, Miho ^a   Miyata, Daiki ^a   Tanaka, Kiyoji ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Blood rheology; Cyanotic congenital heart disease (CCHD); Erythrocytosis; Fibrinolysis; Lipid

Indexed keywords

FIBRINOGEN; HEMOGLOBIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ANALYZER; ARTICLE; BLOOD FLOW; BLOOD RHEOLOGY; BLOOD SAMPLING; BLOOD VISCOSITY; CLINICAL ARTICLE; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; CYANOTIC HEART DISEASE; FEMALE; FIBRINOLYSIS; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HUMAN; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MICROCHANNEL ARRAY FLOW ANALYZER;

ADOLESCENT; ADULT; BLOOD VISCOSITY; CHILD; ERYTHROCYTE INDICES; FEMALE; FIBRINOLYSIS; HEART DEFECTS, CONGENITAL; HEMORHEOLOGY; HUMANS; LIPOPROTEINS; MALE; POLYCYTHEMIA;

EID: 33751363344     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. O.K. Baskurt, O. Yalcin, S. Ozdem, J.K. Armstrong and H.J. Meisselman, Modulation of endothelial nitric oxide synthase expression by red blood cell aggregation, Am. J. Physiol. 286 (2004), H222-H229.
2. R. Ben-Ami, G. Sheinman, S. Yedgar et al., Thrombolytic therapy reduces red blood cell aggregation in plasma without affecting intrinsic aggregability, Thromb. Res. 105 (2002), 487-492.
3. J.F. Brun, Hormones, metabolism and body composition as major determinants of blood rheology: Potential pathophysiological meaning, Clin. Hemorheol. Microcirc. 26 (2002), 63-79.
4. S. Chien, Shear dependence of effective cell volume as a determinant of blood viscosity, Science 168 (1970), 977-978.
5. S. Chien, S. Usami, R.J. Dellenback et al., Comparative hemorheology - Hematological implications of species differences in blood viscosity, Biorheology 8 (1971), 35-57.
6. I. Cicha, Y. Suzuki, N. Tateishi et al., Enhancement of red blood cell aggregation by plasma triglycerides, Clin. Hemorheol. Microcirc. 24 (2001), 247-255.
7. C.L. Devehat, M. Vimeux and T. Khodabandehlou, Blood rheology in patients with diabetes mellitus, Clin. Hemorheol. Microcirc. 30 (2004), 297-300.
8. M.R. Hardeman, Clinical hemorheology, quo vadis?, Clin. Hemorheol. 16 (1996), 11-33.
9. H. Horigome, N. Iwasaki, I. Anno et al., Magnetic resonance imaging of the brain and haematological profile in adult cyanotic congenital heart disease without stroke, Heart 92 (2006), 263-265.
10. H. Horigome, Y. Hiramatsu, O. Shigeta et al., Overproduction of platelet microparticles in cyanotic congenital heart disease with polycythemia, J. Am. Coll. Cardiol. 39 (2002), 1072-1077.
11. H. Horigome, T. Murakami, T. Isobe et al., Soluble P-selectin and thrombomodulin-protein C-Protein S pathway in cyanotic congenital heart disease with secondary erythrocytosis, Thromb. Res. 112 (2003), 223-227.
12. Y. Isogai, S. Ikemoto and H. Tanaka, Elevation of viscosity of blood in non-coagulative and coagulative state in diabetes, as indices of increasing the incidence of aggravation of microangiopathy, Clin. Hemorheol. 16 (1996), 713-735.
13. I. Juhan-Vague, S.D.M. Pyke, M.C. Alessi et al. on behalf of the ECAT Study Group, Fibrinolytic factors and risk of myocardial infarction or sudden death in patients with angina pectoris, Circulation 94 (1996), 2057-2063.
14. H. Kamada, K. Hattori, T. Hayashi and K. Suzuki, In vitro evaluation of blood coagulation activation and microthrombus formation by a microchannel array flow analyzer, Thromb. Res. 114 (2004), 195-203.
15. Y. Katayama, M. Nakagaichi and K. Tanaka, Test-retest repeatability of blood rheological property (blood passage time) using MC-FAN (in Japanese), J. Jpn. Soc. Biorheol. 19 (2005), 100-106.
16. Y. Kikuchi, K. Sato and Y. Mizuguchi, Modified cell-flow microchannels in a single-crystal silicon substrate and flow behavior of blood cells, Microvas. Res. 47 (1994), 126-139.
17. Y. Kikuchi, K. Sato, H. Ohki and T. Kaneko, Optically accessiblemicrochannels formed in a single-crystal silicon substrate for studies of blood rheology, Microvas. Res. 44 (1992), 226-240.
18. W. Koenig and E. Ernst, The possible role of hemorheology in atherothrombogenesis, Atherosclerosis 94 (1992), 93-107.
19. T. Kurihara, S. Deguchi, J. Kato et al., Impaired blood rheology by remnant-like lipoprotein particles: studies in patients with fatty liver disease, Clin. Hemorheol. Microcirc. 24 (2001), 217-225.
20. C.Y.J. Lee, L.I. Kim, H.W. Park et al., Rheological properties of erythrocytes from male hypercholesterolemia, Microvas. Res. 67 (2003), 133-138.
21. G.D.O. Lowe, Blood viscosity and cardiovascular disease, Thromb. Haemost. 67 (1992), 494-498.
22. G.D.O. Lowe, A.J. Lee, J.E. Price and F.G.R. Fowkes, Blood viscosity and risk of cardiovascular events: the Edinburgh artery study, Br. J. Haematol. 96 (1997), 168-173.
23. G.D.O. Lowe, J.W.G. Yarnell, P.M. Sweetnam et al., Fibrin D-dimer, tissue plasminogen activator, plasminogen activator inhibitor, and risk of major ischemic heart disease in the Caerphilly study, Thromb. Haemost. 79 (1998), 129-133.
24. N. Maeda, Erythrocyte rheology in microcirculation, Jpn. J. Physiol. 46 (1996), 1-14.
25. J.K. Perloff, A.J. Marelli and P.D. Miner, Risk of stroke in adults with cyanotic congenital heart disease, Circulation 87 (1993), 1954-1959.
26. R.S. Rosenson, S. Shott, L. Lu and C.C. Tangney, Hypertriglyceridemia and other factors associated with plasma viscosity, Am. J. Med. 110 (2001), 488-492.
27. T. Shiga, N. Maeda and K. Kon, Erythrocyte rheology, Crit. Rev. Oncol. Hematol. 10 (1990), 9-48.
28. T. Shiga, N. Maeda, K. Kon et al., Rheological and kinetic dysfunctions of the cholesterol-loaded, human erythrocytes, Biorheology 16 (1979), 363-369.
29. R. Wei, J.J. Han, B. Bai et al., Analysis of factors influencing the blood levels and activities of tissue-type plasminogen activator (t-PA), Clin. Hemorheol. Microcirc. 29 (2003), 351-356.
30. B.K. William, A.W. Philip, P.C. William and B.D. Ralph, Fibrinogen and risk of cardiovascular disease, JAMA 258 (1987), 1183-1186.